⚑Today
✨Today's leadDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease🎈For kidsSouth Carolina tract beside wildlife refuge to be permanently conserved🌿NatureFormer ocean liner S.S. United States becomes the world's largest artificial reef⚽SportsLindy Duncan wins her first LPGA title on attempt 222🎨Culture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately HeldπŸ”¬Science & healthPeople who control HIV without treatment may help find a cureπŸ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joinedπŸ›οΈPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressureπŸš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

Spinal injury drug may tackle Alzheimer's DNA damage and inflammation

ScienceDaily 3 November 2026 2 min read

In short

  • The drug was originally developed for spinal cord injuries.
  • Researchers found it can address DNA damage and brain inflammation linked to Alzheimer's.
  • The experimental treatment has been tested for initial safety in humans.

Why it's good news

The study points to DNA damage and inflammation as features the drug may target. The treatment is still experimental, and the source reports only initial safety testing in humans. Its value depends on whether later studies show it helps people with the disease.

Advertisement

From ScienceDaily

Scientists have discovered that a drug originally developed for spinal cord injuries can tackle several key features of Alzheimer’s disease, including DNA damage and inflammation. Already tested for initial safety in humans, the experimental treatment could offer a faster path toward therapies that target the disease at its roots.

Read the full story at ScienceDaily Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor